Christiano Robles Rodrigues Alves, D.Ph.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscular Atrophy, Spinal | 5 | 2023 | 259 | 2.560 |
Why?
|
| Muscle, Skeletal | 13 | 2021 | 4925 | 1.630 |
Why?
|
| Creatine | 5 | 2014 | 421 | 1.610 |
Why?
|
| Muscular Atrophy | 5 | 2021 | 347 | 1.530 |
Why?
|
| Resistance Training | 6 | 2023 | 164 | 1.310 |
Why?
|
| Cachexia | 5 | 2021 | 205 | 1.050 |
Why?
|
| Physical Conditioning, Animal | 6 | 2021 | 354 | 1.020 |
Why?
|
| Carcinoma, Lewis Lung | 2 | 2023 | 114 | 0.890 |
Why?
|
| Athletic Performance | 2 | 2015 | 95 | 0.870 |
Why?
|
| Oxidative Stress | 3 | 2021 | 3082 | 0.770 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2020 | 64 | 0.730 |
Why?
|
| Sucrose | 1 | 2019 | 164 | 0.660 |
Why?
|
| Action Potentials | 2 | 2020 | 1804 | 0.540 |
Why?
|
| Athletes | 2 | 2015 | 1093 | 0.530 |
Why?
|
| Gymnastics | 1 | 2015 | 26 | 0.520 |
Why?
|
| Anaerobic Threshold | 1 | 2015 | 51 | 0.520 |
Why?
|
| Nerve Degeneration | 1 | 2019 | 748 | 0.510 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2023 | 610 | 0.500 |
Why?
|
| RNA-Binding Proteins | 1 | 2023 | 1900 | 0.490 |
Why?
|
| Creatinine | 1 | 2019 | 1918 | 0.480 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2018 | 1108 | 0.440 |
Why?
|
| Dietary Supplements | 3 | 2014 | 3292 | 0.430 |
Why?
|
| Osteosarcoma | 1 | 2018 | 881 | 0.420 |
Why?
|
| Survival of Motor Neuron 2 Protein | 2 | 2023 | 48 | 0.420 |
Why?
|
| Exercise | 5 | 2023 | 5611 | 0.410 |
Why?
|
| Running | 2 | 2018 | 479 | 0.400 |
Why?
|
| Muscular Diseases | 1 | 2014 | 555 | 0.360 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 2 | 2022 | 108 | 0.360 |
Why?
|
| Rats, Wistar | 5 | 2021 | 1892 | 0.350 |
Why?
|
| Fibromyalgia | 1 | 2013 | 388 | 0.330 |
Why?
|
| Repressor Proteins | 1 | 2020 | 3024 | 0.330 |
Why?
|
| Muscle Strength | 4 | 2014 | 592 | 0.330 |
Why?
|
| Anthropometry | 2 | 2014 | 1348 | 0.310 |
Why?
|
| Exercise Therapy | 1 | 2014 | 904 | 0.310 |
Why?
|
| Exercise Test | 1 | 2015 | 2074 | 0.300 |
Why?
|
| Memory, Short-Term | 1 | 2014 | 976 | 0.300 |
Why?
|
| Oxidation-Reduction | 3 | 2021 | 2183 | 0.280 |
Why?
|
| Neoplasms | 4 | 2021 | 21675 | 0.270 |
Why?
|
| Glucose | 3 | 2022 | 4398 | 0.270 |
Why?
|
| Bone Neoplasms | 1 | 2018 | 2529 | 0.270 |
Why?
|
| Psychomotor Performance | 1 | 2014 | 1895 | 0.260 |
Why?
|
| Motor Neurons | 2 | 2019 | 841 | 0.250 |
Why?
|
| SMN Complex Proteins | 1 | 2023 | 42 | 0.240 |
Why?
|
| Platelet Factor 4 | 1 | 2023 | 129 | 0.230 |
Why?
|
| Executive Function | 1 | 2012 | 1361 | 0.230 |
Why?
|
| Stroop Test | 2 | 2014 | 62 | 0.230 |
Why?
|
| Rats | 6 | 2021 | 24250 | 0.230 |
Why?
|
| Attention | 1 | 2014 | 2393 | 0.220 |
Why?
|
| Nutritional Status | 1 | 2011 | 1608 | 0.220 |
Why?
|
| Emotions | 1 | 2013 | 2656 | 0.200 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2021 | 49 | 0.200 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2022 | 162 | 0.200 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2021 | 69 | 0.200 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2020 | 59 | 0.180 |
Why?
|
| Animals | 16 | 2023 | 168660 | 0.180 |
Why?
|
| Bone Density | 2 | 2014 | 3460 | 0.180 |
Why?
|
| Cognition | 2 | 2014 | 6759 | 0.170 |
Why?
|
| Oxidative Phosphorylation | 1 | 2021 | 480 | 0.170 |
Why?
|
| Oligonucleotides | 1 | 2022 | 572 | 0.170 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2021 | 403 | 0.160 |
Why?
|
| Myoblasts | 1 | 2020 | 238 | 0.160 |
Why?
|
| Carcinoma 256, Walker | 1 | 2018 | 39 | 0.160 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2019 | 75 | 0.160 |
Why?
|
| Disease Progression | 3 | 2021 | 13273 | 0.160 |
Why?
|
| Energy Metabolism | 2 | 2020 | 2899 | 0.160 |
Why?
|
| Adipose Tissue, White | 1 | 2021 | 351 | 0.160 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 2018 | 136 | 0.160 |
Why?
|
| Exons | 1 | 2023 | 2438 | 0.150 |
Why?
|
| Muscle Fatigue | 1 | 2017 | 82 | 0.150 |
Why?
|
| Glycolysis | 1 | 2021 | 830 | 0.150 |
Why?
|
| Physical Therapy Modalities | 1 | 2011 | 549 | 0.150 |
Why?
|
| Mice | 8 | 2023 | 81154 | 0.150 |
Why?
|
| Oxygen Consumption | 2 | 2015 | 1869 | 0.140 |
Why?
|
| Adaptation, Physiological | 2 | 2021 | 1311 | 0.140 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2020 | 555 | 0.140 |
Why?
|
| Adipokines | 1 | 2019 | 320 | 0.140 |
Why?
|
| Acetylcysteine | 1 | 2017 | 271 | 0.140 |
Why?
|
| Double-Blind Method | 4 | 2014 | 12020 | 0.140 |
Why?
|
| Cell Count | 1 | 2019 | 1855 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 1656 | 0.130 |
Why?
|
| Fluorine Radioisotopes | 1 | 2018 | 443 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 20121 | 0.130 |
Why?
|
| Cysteine | 1 | 2018 | 871 | 0.120 |
Why?
|
| Muscle Stretching Exercises | 1 | 2014 | 33 | 0.120 |
Why?
|
| Hyperalgesia | 1 | 2018 | 502 | 0.120 |
Why?
|
| Male | 16 | 2021 | 349776 | 0.120 |
Why?
|
| Lower Extremity | 1 | 2011 | 1158 | 0.110 |
Why?
|
| Early Diagnosis | 1 | 2018 | 1186 | 0.110 |
Why?
|
| Phosphocreatine | 1 | 2013 | 270 | 0.110 |
Why?
|
| Trail Making Test | 1 | 2012 | 57 | 0.110 |
Why?
|
| Muscle Contraction | 1 | 2017 | 1233 | 0.110 |
Why?
|
| Rats, Inbred SHR | 1 | 2012 | 195 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 15526 | 0.100 |
Why?
|
| Colonic Neoplasms | 1 | 2023 | 2542 | 0.100 |
Why?
|
| Femur | 1 | 2018 | 1296 | 0.100 |
Why?
|
| Ships | 1 | 2011 | 61 | 0.100 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2012 | 250 | 0.100 |
Why?
|
| Fasting | 1 | 2017 | 1590 | 0.100 |
Why?
|
| Learning | 1 | 2011 | 1710 | 0.100 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 1937 | 0.100 |
Why?
|
| Fatty Acids | 1 | 2019 | 1809 | 0.090 |
Why?
|
| Heart Rate | 2 | 2012 | 4091 | 0.090 |
Why?
|
| Heart Failure | 1 | 2014 | 10896 | 0.090 |
Why?
|
| Osteoarthritis, Knee | 1 | 2011 | 1222 | 0.090 |
Why?
|
| Female | 15 | 2023 | 380020 | 0.090 |
Why?
|
| Humans | 19 | 2023 | 743811 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2012 | 480 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 489 | 0.090 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2014 | 417 | 0.090 |
Why?
|
| Infant | 3 | 2021 | 35122 | 0.090 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2022 | 2407 | 0.090 |
Why?
|
| Antioxidants | 1 | 2017 | 1658 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2023 | 16674 | 0.090 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2014 | 1335 | 0.080 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 12066 | 0.080 |
Why?
|
| Radiopharmaceuticals | 1 | 2018 | 2647 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 11729 | 0.080 |
Why?
|
| Receptor, Insulin | 1 | 2012 | 846 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2022 | 21824 | 0.080 |
Why?
|
| Brazil | 1 | 2011 | 1264 | 0.070 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 2029 | 0.070 |
Why?
|
| Proteomics | 1 | 2020 | 3639 | 0.070 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 9731 | 0.070 |
Why?
|
| Food | 1 | 2011 | 771 | 0.070 |
Why?
|
| Lactic Acid | 1 | 2011 | 1131 | 0.070 |
Why?
|
| Middle Aged | 9 | 2023 | 213241 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2022 | 3750 | 0.070 |
Why?
|
| Protein Transport | 1 | 2012 | 1988 | 0.070 |
Why?
|
| Body Composition | 2 | 2014 | 2401 | 0.070 |
Why?
|
| Cytokines | 1 | 2020 | 7324 | 0.060 |
Why?
|
| Adipose Tissue | 2 | 2019 | 3280 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 9440 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 15067 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2021 | 25609 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2020 | 23398 | 0.060 |
Why?
|
| Splenomegaly | 1 | 2023 | 190 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 2504 | 0.060 |
Why?
|
| Apoptosis | 1 | 2019 | 9718 | 0.050 |
Why?
|
| Self Report | 1 | 2013 | 3550 | 0.050 |
Why?
|
| Medication Adherence | 1 | 2013 | 2063 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2012 | 4026 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 18027 | 0.050 |
Why?
|
| Inguinal Canal | 1 | 2021 | 69 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2018 | 8939 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 6976 | 0.050 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2021 | 93 | 0.050 |
Why?
|
| Cell Transdifferentiation | 1 | 2021 | 172 | 0.040 |
Why?
|
| Biopsy | 1 | 2012 | 6750 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2022 | 595 | 0.040 |
Why?
|
| Malate Dehydrogenase | 1 | 2018 | 41 | 0.040 |
Why?
|
| Eating | 2 | 2017 | 1536 | 0.040 |
Why?
|
| Cell Respiration | 1 | 2018 | 199 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2020 | 40964 | 0.040 |
Why?
|
| Muscles | 1 | 2022 | 1613 | 0.040 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2022 | 735 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 19894 | 0.040 |
Why?
|
| Age Factors | 1 | 2013 | 18355 | 0.040 |
Why?
|
| Physical Endurance | 1 | 2018 | 370 | 0.030 |
Why?
|
| Anorexia | 1 | 2016 | 161 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2016 | 424 | 0.030 |
Why?
|
| Adolescent | 2 | 2015 | 85729 | 0.030 |
Why?
|
| Diet | 1 | 2013 | 7930 | 0.030 |
Why?
|
| Triglycerides | 1 | 2023 | 2453 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 2006 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2023 | 6380 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2023 | 1580 | 0.030 |
Why?
|
| Exercise Tolerance | 1 | 2018 | 768 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2023 | 2037 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2011 | 1828 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 2429 | 0.030 |
Why?
|
| Placenta | 1 | 2022 | 1699 | 0.030 |
Why?
|
| Aged | 4 | 2023 | 163178 | 0.030 |
Why?
|
| Histones | 1 | 2022 | 2598 | 0.030 |
Why?
|
| Child | 1 | 2019 | 77637 | 0.030 |
Why?
|
| Adult | 3 | 2020 | 213889 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 1986 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2021 | 2583 | 0.020 |
Why?
|
| Reference Values | 1 | 2017 | 4974 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2020 | 4162 | 0.020 |
Why?
|
| Family | 1 | 2020 | 3144 | 0.020 |
Why?
|
| Sarcopenia | 1 | 2014 | 368 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2023 | 4286 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2023 | 13028 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 57744 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2014 | 1725 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 63042 | 0.020 |
Why?
|
| Body Weight | 1 | 2017 | 4670 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 2916 | 0.020 |
Why?
|
| Myocardium | 1 | 2018 | 4775 | 0.020 |
Why?
|
| Young Adult | 1 | 2011 | 56392 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 13980 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2021 | 19232 | 0.020 |
Why?
|
| Motor Activity | 1 | 2014 | 2714 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2014 | 2683 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12786 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 8637 | 0.010 |
Why?
|
| Quality of Life | 1 | 2023 | 12788 | 0.010 |
Why?
|
| Pregnancy | 1 | 2022 | 29140 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 40545 | 0.010 |
Why?
|
| Time Factors | 1 | 2017 | 40038 | 0.010 |
Why?
|